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Objectives: To define the early and midterm outcomes after thoracic endovascular aortic repair (TEVAR) of blunt thoracic aortic injury (BTAI).
Methods: Clinical data of consecutive patients who underwent TEVAR (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) for BTAI were retrospectively reviewed. Primary end points were major adverse events and mortality; secondary end points were complications and reinterventions.
Results: Eighteen patients underwent TEVAR for BTAI (female, 11, 61%; median age, 29 years, range, 16-85 years). Cause of trauma included motor vehicle accident (n ¼ 15, 83%), motorcycle accident (n ¼ 1, 5.6%), and fall (n ¼ 2, 11%); median injury severity score was 36 (range: 4-59). Aortic injuries involved zones 2 to 3 (n ¼ 1), zone 3 (n ¼ 12), zones 3 to 4 (n ¼ 3), and zone 5 (n ¼ 2). TEVAR was performed at a median of 1 day (range: 0-6 days) from aortic injury, devices from 3 manufacturers were used (Gore: 15, Medtronic: 2, Cook 1). Left subclavian artery was partially covered in 2 patients (11%), and completely covered in 2 patients (11%) with reconstruction using chimney technique. Seven patients (39%) had concomitant surgeries (orthopedic: five; abdominal: three) and seven (39%) had staged orthopedic surgeries after TEVAR. Technical success was 100%. No intraoperative death occurred. Thirty-day mortality was 11% (n ¼ 2), major adverse event rate was 33% (n ¼ 6). Rates of respiratory failure, stroke, deep venous thrombosis (DVT) and pulmonary embolism were 17% (n ¼ 3), 11% (n ¼ 2), 22% (n ¼ 4), and 11% (n ¼ 2), respectively. Temporary IVC filter was placed in seven patients (39%, preoperative: 1; postoperative: 6). Median follow-up was 3.1 years (range: 2 days to 0.5 years). There were no TEVAR-related or device-related complications or reinterventions. There were two late deaths, nonaortic related. Three-year survival was 89%.
Conclusions: BTAI patients were young and usually polytraumatic requiring healthcare by a multidisciplinary team. TEVAR/device-related complications and reinterventions were low in our series; however, data on device-related long-term outcomes and aortic remodeling in particular for younger patients are needed.
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Ten-Year Experience With TEVAR for Traumatic Aortic Injury
Thomas J. Desmarais, Naveen K. Pokala, Senthil N. Jayarajan, Gerald R. Fortuna Jr, Luis A. Sanchez, Jeffrey Jim. Washington University School of Medicine, St Louis, Mo
Objectives: Review the 10-year single institution experience with blunt traumatic aortic injury (BTAI) and outcomes with thoracic endovascular aortic repair (TEVAR).
Methods: Retrospective evaluation of all patients with BTAI presenting to a single center between July 2006 and September 2016.
Results: There were 52 patients identified with BTAI (7 grade I, 1 grade II, 41 grade III, 3 grade IV). There were males 38 (73%) with a mean age of 42 years (range 18-84 years). The median injury severity score was 34 (interquartile range, 29-44). There were 13 patients that did not undergo aortic repair with 8 deaths from their injuries and 5 patients with stable grade I/II injuries. One patient received open repair owing to anatomic considerations. TEVAR was performed in the remaining 38 patients of which there were 29 (76%) males with a mean age of 40 (range, 18-78). Technical success was achieved in 37 (97%) patients with one instance of device misdeployment requiring conversion to open repair. Intentional left subclavian artery coverage was required in 19 (51%) and subclavian revascularization was performed in 8 patients with 4 in a delayed fashion owing to the development of arm claudication. There were two (5.2%) postoperative strokes. The 30-day mortality rate was 3% with one intraoperative death owing to a myocardial infarction. There were eight (21%) other deaths within a median of 40.5 months (range 3-105 months). The remaining 28 patients are alive with a median follow-up of 33 months (range 1-112 months). There have been no instances of endoleak, device migration, aortic degeneration or need for secondary aortic intervention.
Conclusions: TEVAR is effective for patients with BTAI with high rates of technical success and low rates of complications. Coverage of the left subclavian artery can be safely performed without revascularization in select situations. Obtaining long-term follow-up remains challenging.
Author Disclosures: T. J. Desmarais: Nothing to disclose; G. R. Fortuna: Nothing to disclose; S. N. Jayarajan: Nothing to disclose; J. Jim: Medtronic: Consulting fees (eg, advisory boards), Speaker's Bureau, Silk Road Medical: Consulting fees (eg, advisory boards), Speaker's Bureau; N. K. Pokala: Nothing to disclose; L. A. Sanchez: Bolton: Consulting fees (eg, advisory boards), COOK: Consulting fees (eg, advisory boards), Endologix: Consulting fees (eg, advisory boards), Gore: Consulting fees (eg, advisory boards). Objectives: To describe contemporary management patterns for patients hospitalized with blunt thoracic aortic injury (BTAI) and to identify factors associated with BTAI management strategy and in-hospital mortality after BTAI.
PC204.
Contemporary Management Patterns for Blunt
Methods: Our study included patients from the 2011 to 2015 National Trauma Data Bank who were hospitalized after sustaining BTAI. Patients who died in the emergency department (ED) or sustained any type of nonsurvivable injury were excluded. To account for missing data, multiple imputation was performed using chained equations with averaged predictions and adjusted standard errors for uncertainty. Multinomial logistic regression analysis was used to separately identify predictors of endovascular and open BTA repair [versus nonoperative management (NOM)] after adjustment for demographic characteristics, comorbid conditions, and injury severity/location. A separate multinomial logistic regression was then used to identify predictors of in-hospital mortality after BTAI.
Results: A total of 5767 adult patients with BTAI who survived initial ED triage and who were without any injuries deemed nonsurvivable were included for analysis. Of these patients, 3,319 (57.6%) underwent NOM while 2448 (42.5%) underwent operative repair [2022 (35.1%) 
